The Global One Health initiative (GOHi) hosted training for 13 laboratory technology professionals from Ethiopian and Kenyan institutes at the Kenya Medical Research Institute (KEMRI) as part of the OHEART program.
Tagged: Global One Health
GOHi helps establish two molecular diagnostics labs in Ethiopia
The Ohio State Global One Health initiative (GOHi), through the U.S. Centers for Disease Control and Prevention (CDC) Coronavirus Aid, Relief, and Economic Security (CARES) Act, helped establish advanced molecular diagnostic laboratory capabilities. These labs will strengthen the national surveillance and response system by enabling the detection of infectious diseases such as influenza, COVID-19 and other pathogens of public health significance.
Service initiation program for molecular diagnostics laboratories
As part of the International Health Regulation (IHR)-U.S. Centers for Disease Control and Prevention (CDC) Coronavirus Aid, Relief and Economic Security (CARES) Act, the Global One Health initiative (GOHi) helped establish four molecular diagnostic laboratories for influenza and other respiratory pathogens testing in Addis Ababa, Bahir Dar, Arba Minch and Adama.
GOHi hosts LMG workshop for Ethiopian higher education leaders
The Leadership, Management, and Governance (LMG) program in Ethiopian Higher Education aims to enhance the capacity of Ethiopian public higher education leaders. Funded by the U.S. Department of State's Bureau of African Affairs, the program is part of the Ministry of Education's strategy towards improving the overall governance of the higher education system in Ethiopia and enhancing the quality of education and research.
Strengthening vaccine pharmacovigilance system in Ethiopia
The Global One Health initiative (GOHi), in collaboration with the Ethiopian Food and Drug Administration Authority (EFDA), organized a project kickoff and sensitization workshop about adverse events following immunizations (AEFI) in August in Addis Ababa, Ethiopia.
GOHi initiated sero-prevalence study on SARS-CoV-2 in Ethiopia
The Ohio State Global One Health initiative (GOHi) is collaborating with the Ethiopian Public Health Institute (EPHI), U.S. Centers for Disease and Control (CDC), Africa CDC and World Health Organization (WHO) to carry out a cross-sectional, population-based sero-prevalence study on COVID-19. This study will involve more than 14,000 households in Ethiopia.
Risk ranking exercise conducted on food hazards in Ethiopia
Ethiopia bears a significant burden of foodborne illnesses. The Global One Health initiative (GOHi) has been working on the Assessment and Risk Management of Foodborne Illnesses (TARTARE) – a food safety project – since 2019. The overarching goal of this project is to reduce morbidity and mortality from foodborne diseases.
RT-PCR training for influenza testing labs in Ethiopia
The Ohio State Global One Health initiative (GOHi), in partnership with U.S. Centers for Disease Control (CDC), has established four severe acute respiratory infection (SARI)/influenza-like illness (ILI) testing laboratories in Ethiopia, including regional and sub-regional labs in Addis Ababa, Bahir Dar, Adama and Arba Minch.
GOHi provides NGS training in Ethiopia
The Ethiopian Public Health Institute (EPHI) has established a Genomic Core Facility operated by a team of 12 experts from different divisions. This facility aims to fill in the gaps in genomic workflows and strengthen the capacity for genomic data analysis.
GOHi supports causality assessment in Ethiopia
Ohio State’s Global One Health initiative (GOHi) is supporting the Ethiopian Food and Drug Authority (EFDA) in undertaking a causality assessment of adverse events following immunizations (AEFI), mainly with COVID-19 vaccines, that were reported to the pharmacovigilance system. As part of GOHi’s continued support to the EFDA, 30 participants – including members of the pharmacovigilance advisory committee, experts of the pharmacovigilance team at EFDA and advisors – conducted the assessment on July 19 and 20.